Clinical Trials Logo

Clinical Trial Summary

Subjects will participate in a 4-visit study protocol at the National Advanced Driving Simulator, part of the University of Iowa, in which they will be asked to complete assorted questionnaires, computerized cognitive tasks, and a simulator drive. Subjects will be administered 0.75 mg alprazolam (Xanax) or placebo and 500 mg vaporized cannabis (6.18% THC / <0.025% CBD) or placebo (0% THC / 0% CBD). The primary objective of this study is to validate the Drug Impaired Driving Scenario (DIDS) using the CRCDS-2 driving simulator by assessing the acute effects of cannabis relative to placebo on simulated driving performance. Assay sensitivity will be demonstrated by the significant effect of 0.75 mg alprazolam (active comparator) on driving and cognitive endpoints.


Clinical Trial Description

At the University of Iowa's National Advanced Driving Simulator (NADS), normal healthy subjects who currently use cannabis recreationally (at least once a month) will be recruited. The study involves four visits, the first of which is a screening visit of approximately 3 hours. At the screening visit, consent is obtained, questionnaires are given, and a physical and psychological exam is administered. Subjects will also train on study procedures, such as the cognitive testing, the simulator drive, and the cannabis inhalation procedure. Subjects will then be scheduled for their three treatment visits, which will be one week apart.. The treatment visits will have a clean (double placebo) and two treatment visits (active alprazolam and placebo cannabis, placebo alprazolam and active cannabis). The alprazolam dose is 0.75 mg and the cannabis dose is 500 mg. All cannabis will be inhaled via a Volcano® Digit vaporizer using the Foltin Puff Procedure. Each of the treatment visits will last approximately twenty-three hours and will include intake with eligibility and baseline testing, transport to a local hotel, an overnight stay at the hotel, transport to NADS, being dosed with study drugs or placebos, cognitive assessments, a simulator drive, and assorted questionnaires. There will also be 8 mL blood sampling before dosing, before driving, and after driving. Each randomized subject will complete a treatment visit of each type one week apart in a counterbalanced sequence. Meals will be provided at the treatment visits (dinner, snack, breakfast, lunch). Subjects will be monitored until the drug effects have subsided sufficiently to ensure it is safe to transport them home. Subjects will need to arrange their own transportation; they will not be permitted to drive themselves home after the treatment visits. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04970342
Study type Interventional
Source University of Iowa
Contact
Status Completed
Phase Phase 1
Start date July 16, 2021
Completion date August 21, 2021

See also
  Status Clinical Trial Phase
Completed NCT00648206 - Testing Alcohol Only Samples for Drugs and Drugs Only Samples for Alcohol N/A
Completed NCT04230460 - Cannabis Impairment Detection Application (CIDA) N/A
Completed NCT03506880 - Project MADD - NIH Underage DUI and Ride N/A
Completed NCT05028413 - Evaluating Perceived Fitness to Drive While Intoxicated N/A
Completed NCT02071836 - A Web Application to Reduce Heavy Drinking in First-time DWI Offenders N/A
Completed NCT00650130 - Whole Blood-plasma-oral Fluid Ratios of Psychoactive Drugs and Medicines N/A
Recruiting NCT04450966 - Adolescent Substance Use Prevention Intervention Research Study in Pediatric Primary Care N/A
Completed NCT04247191 - Parent Intervention to Reduce College Student Drinking and Consequences N/A
Completed NCT03335735 - Smartphone-paired Breathalyzers and Loss- and Gain-framed Texts for Reducing Drinking and Driving N/A
Active, not recruiting NCT01590277 - Ability of Partial Inverse Agonist, Iomazenil, to Block Ethanol Effects in Humans Phase 1
Withdrawn NCT05273658 - Effects of Cannabis/Alcohol on Driving Performance and Field Sobriety Tests Phase 1/Phase 2
Completed NCT05437081 - A Family-Based Alcohol Preventive Intervention for Latino Emerging Adults N/A
Not yet recruiting NCT05526196 - Combined and Separate Effects of Cannabis and Tobacco: Psychomotor, Subjective and Physiological Outcomes N/A
Completed NCT03503396 - Alcohol Impaired Driving in the Natural Environment N/A